Fed, FDIC, OCC Seek More Information From Banks on Bank-fintech Arrangements
Alphabet Stock Falls As OpenAI Plans 'SearchGPT': What Investors Need To Know
Is the weight loss drug field about to change? Viking Therapeutics surged nearly 40% intraday, causing eli lilly and co's market cap to shrink by $120 billion.
After communicating with regulatory institution FDA, USA's Viking Therapeutics unexpectedly made progress in advancing weight loss drug VK2735 to phase III clinical trials, which may lead to an advance of its launch time by one year. This drug is expected to be injected once a month, which is more convenient than the same magical medicine from Eli Lilly and Novo Nordisk. The oral version of VK2735 will start phase II trials in the fourth quarter of this year. Coupled with the bullish news from Swiss pharmaceutical company Roche in the same field, Eli Lilly's stock has fallen by 14% in eight trading days, the worst since 2020, reducing its market cap by more than 120 billion USD from its peak.
OpenAI Begins Testing AI-powered Search; GOOG Slips 2%
ServiceNow CEO Highlights Long-Running Partnership With Nvidia, 'Lightening Fast' AI Models That Run Inexpensively: 'We're The Unicorn'
Apple Rises as Baird Bumps Price Target on AI Opportunity
Viking Therapeutics Stock Surges 31% As Company Advances Weight Loss Drug To Late-Stage Trial
10 Information Technology Stocks Whale Activity In Today's Session
Why Eli Lilly and Company Shares Are Moving Lower On Thursday
Google's AI Models Achieve New Heights in Olympic Problem Solving
Musk Says Will Take XAI Investment to Tesla Board After Poll Results
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Microsoft's Progressive Stance Paves Way for Unionized Gaming Workforce
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
Goldman Sachs: Time To Hedge? Goldman's Flow-Of-Funds Guru Scott Rubner Suggests Hedging. Here Are Inexpensive Ways To Do So Ahead Of Mag 7 Earnings Next Week
Market Clubhouse Morning Memo - July 25th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)
Microsoft Options Trading: A Deep Dive Into Market Sentiment
Apple's Taiwanese Chip Supplier ASE Tech Clocks Modest Q2 Growth In Revenues
Fabrinet: The AI Secret Weapon Powering Nvidia's Data Center Boom
Today's Morning Movers and Top Ratings: NVDA, CMG, F, AAL and More